Cleared Traditional

K111555 - CIRCUMAURAL ADHESIVE REPLACEMENT

K111555 is an FDA 510(k) clearance for CIRCUMAURAL ADHESIVE REPLACEMENT, manufactured by R & D Medical Products, Inc.. The device is a Class 2 Neurology device with product code GWJ cleared through the Traditional 510(k) pathway after a 52-day FDA review.

K111555 · R & D Medical Products, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2011
Decision
52d
Days
Class 2
Risk

K111555 is an FDA 510(k) clearance for the CIRCUMAURAL ADHESIVE REPLACEMENT. Classified as Stimulator, Auditory, Evoked Response (product code GWJ), Class II - Special Controls.

Submitted by R & D Medical Products, Inc. (Lake Forest, US). The FDA issued a Cleared decision on July 25, 2011 after a review of 52 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1900 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all R & D Medical Products, Inc. devices

FDA 510(k) Submission Details - K111555

510(k) Number K111555 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 03, 2011
Decision Date July 25, 2011
Days to Decision 52 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
96d faster than avg
Panel avg: 148d · This submission: 52d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GWJ Device Classification - Class 2, Special Controls

Product Code GWJ Stimulator, Auditory, Evoked Response
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1900
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWJ Stimulator, Auditory, Evoked Response

All 27
Devices cleared under the same product code (GWJ) and FDA review panel - the closest regulatory comparables to K111555.
ALGO 7i
K211147 · Path Medical GmbH · Oct 2021
GSI Audera Pro
K193033 · Grason Stadler · Apr 2020
Eclipse with VEMP
K162037 · Interacoustics A/S · Mar 2017
TITAN
K103760 · Interacoustics A/S · May 2011
BIO-LOGIC MASTER II EVOKED RESPONSE SYSTEM
K073626 · Bio-Logic Systems Corp. · Feb 2008
INTERACOUSTICS ASSR, ECLIPSE SYSTEM (CABINET NAME)
K070696 · Interacoustics A/S · Jun 2007